|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net income (loss) | ||
| Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities: | ||
| Amortization expenses | ||
| Depreciation expenses | ||
| Allowance for inventory valuation | ||
| (Reversal of) provision for allowance for expected credit losses | ||
| Fair value changes of investment in equity securities | ||
| Fair value changes of short-term investments | ||
| Expensed deferred initial public offering cost | ||
| (Gain) loss on disposal of property, plant and equipment | ||
| Gain on extinguishment of consulting expenses payable | ||
| Deferred tax expenses | ||
| Changes in operating assets and liabilities: | ||
| Inventories | ||
| Contract assets | ||
| Accounts receivable | ||
| Notes receivable | ||
| Prepayments and other receivables | ||
| Advance to suppliers | ||
| Refundable liabilities | ||
| Accounts, other payables, accruals and income taxes payable | ||
| Notes payable | ||
| Contract liabilities | ||
| Operating lease liabilities | ||
| Other current assets | ||
| Other long-term assets | ||
| Net cash (used in) provided by operating activities | ||
| Cash flows from investing activities: | ||
| Purchase of short-term investments | ||
| Proceeds from disposal of short-term investments | ||
| Purchase of property, plant and equipment | ||
| Proceeds from disposal of property, plant and equipment | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Payment of deferred costs related to initial public offering | ||
| Net proceeds from share over-allotment | ||
| Payment of deferred offering cost | ||
| Dividends paid | ||
| Advance from related parties | ||
| Repayments to related parties | ||
| Proceeds from bank loans | ||
| Repayments on bank loans | ||
| Net cash provided by (used in) financing activities | ||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||
| Net (decrease) increase in cash and cash equivalents, and restricted cash | ||
| Cash and cash equivalents, and restricted cash at beginning of the year | ||
| Cash and cash equivalents, and restricted cash at end of the year | ||
| Reconciliation to amounts on consolidated balance sheet | ||
| Cash and cash equivalents | ||
| Restricted cash | ||
| Total cash, cash equivalents and restricted cash shown in the Consolidated Statements of Cash Flows | ||
| Supplemental disclosure of cash flow information | ||
| Cash received for interest | ||
| Cash paid for interests | ||
| Cash paid for income tax | ||
| Supplemental disclosures of non-cash financing and investing activities | ||
| Right-of-use assets obtained in exchange for new operating lease liabilities | ||
| Capitalization of deferred offering cost |
Loading...
